Inventor
MICHON FRANCIS
US31 patents
⚠️ This page may combine multiple inventors who share the name “MICHON FRANCIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BAXTER INT
7 patentsUS6248570B1Jun 19, 2001
Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccines
BAXTER INT101 citations97
US6372222B1Apr 16, 2002
Antigenic group B Streptococcus type II and type III polysaccharide fragments having a 2, 5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
BAXTER INT41 citations94
US6451317B1Sep 17, 2002
Immunogenic conjugates comprising a Group B meningococcal porin and an H influenzae polysaccharide
BAXTER INT37 citations90
US6764686B2Jul 20, 2004
Modified immunogenic pneumolysin compositions as vaccines
BAXTER INT15 citations79
US6602508B2Aug 5, 2003
Method of immunization using a Group B Streptococcus type II and type III polysaccharide conjugate vaccine
BAXTER INT11 citations71
US6267961B1Jul 31, 2001
Direct methods for molar-mass determination of fragments of Haemophilus influenzae type b capsular polysaccharides and vaccine preparation
BAXTER INT3 citations54
US6613336B2Sep 2, 2003
Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide
BAXTER INT1 citations50
CA NAT RESEARCH COUNCIL
7 patentsUS5576002ANov 19, 1996
Meningococcal polysaccharide conjugate vaccine
CA NAT RESEARCH COUNCIL46 citations96
US5811102ASep 22, 1998
Modified meningococcal polysaccharide conjugate vaccines
CA NAT RESEARCH COUNCIL62 citations94
US5773007AJun 30, 1998
Vaccine compositions
CA NAT RESEARCH COUNCIL70 citations94
US5902586AMay 11, 1999
Meningococcal polysaccharide conjugate vaccine
CA NAT RESEARCH COUNCIL19 citations92
US5225331AJul 6, 1993
Immunoassay for detecting group b streptococcus
CA NAT RESEARCH COUNCIL38 citations89
US5683699ANov 4, 1997
Meningococcal polysaccharide conjugate vaccine
CA NAT RESEARCH COUNCIL16 citations82
US6596283B2Jul 22, 2003
Meningococcal polysaccharide conjugate vaccines
CA NAT RESEARCH COUNCIL2 citations61
WELLSTAT VACCINES LLC
5 patentsUS10964415B2Mar 30, 2021
Automated systems and methods for obtaining, storing, processing and utilizing immunologic information of an individual or population for various uses
WELLSTAT VACCINES LLC3 citations68
US10988552B2Apr 27, 2021
Antibodies targeted to fungal cell wall polysaccharides
WELLSTAT VACCINES LLC0 citations57
US10752704B2Aug 25, 2020
Antibodies targeted to fungal cell wall polysaccharides
WELLSTAT VACCINES LLC0 citations46
US10519253B2Dec 31, 2019
Antibodies targeted to fungal cell wall polysaccharides
WELLSTAT VACCINES LLC0 citations46
US10259888B2Apr 16, 2019
Antibodies targeted to fungal cell wall polysaccharides
WELLSTAT VACCINES LLC0 citations46
NORTH AMERICAN VACCINE INC
3 patentsUS5866135AFeb 2, 1999
Group A streptococcal polysaccharide immunogenic compositions and methods
NORTH AMERICAN VACCINE INC32 citations91
US5425946AJun 20, 1995
Vaccines against group C Neisseria meningitidis
NORTH AMERICAN VACCINE INC73 citations91
US6284884B1Sep 4, 2001
Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
NORTH AMERICAN VACCINE INC0 citations45
MICHON FRANCIS
3 patentsUS8234129B2Jul 31, 2012
Systems and methods for obtaining, storing, processing and utilizing immunologic and other information of individuals and populations
MICHON FRANCIS26 citations88
US8498879B2Jul 30, 2013
Automated systems and methods for obtaining, storing, processing and utilizing immunologic information of individuals and populations for various uses
MICHON FRANCIS13 citations79
US8598337B2Dec 3, 2013
Method for purifying polysaccharides
MICHON FRANCIS5 citations69